Successful embolization for uterine hemorrhage in a patient with acute promyelocytic leukemia

Acta Haematologica
S KatagiriT Kitani

Abstract

A successful embolization for life-threatening uterine hemorrhage is described in a patient with acute promyelocytic leukemia and disseminated intravascular coagulation. On admission the patient was in the 6th week of gestation with incomplete abortion and uterine hemorrhage. In addition to combination chemotherapy and anticoagulant therapy, dilatation and curettage were also performed. After the operation the uterine hemorrhage was progressively increased in amount and was not responsive to usual measures. Embolization of bilateral uterine arteries using Gelfoam was performed with a dramatic improvement of the hemorrhage.

Citations

Feb 26, 2004·International Journal of Hematology·Ugo ConsoliRosario Giustolisi
Jun 26, 2015·Leukemia & Lymphoma·Vivek VermaVijaya Raj Bhatt
Jan 15, 1985·American Journal of Obstetrics and Gynecology·D M Rosenthal, R Colapinto
May 1, 2007·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Alexander M Quaas, Elizabeth S Ginsburg
May 30, 2009·Pharmacotherapy·Daisy Yang, Lindsay Hladnik
Sep 25, 2001·American Journal of Obstetrics and Gynecology·L BorgattaW K Rashbaum
Jan 9, 2017·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Yolanda A KirkhamSarah McQuillan
Dec 1, 1995·Cancer·M A HoffmanG J Kleiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.